from Françoise Le Vacon, Chief Scientific Officer at Biofortis Mérieux NutriSciences.
Cancer is a leading cause of morbidity and mortality worldwide, with the most common cancers occurring in lung, breast, and prostate.
Some chronic infections that particularly affect low and middle-income countries are risk factors for cancer. The main five behavioral and dietary risk factors are high body mass index, low fruit and vegetable consumption, lack of execerse, smoking and alcohol consumption. To fight cancer, many public and private organizations contribute to the lobal research effort. The latest findings on the possible role of the microbiome in some caner treatment responses appear promising. Thus, I am convinced that the microbiome field will offer new opportunities to develop patient stratification strategies and new adjuvant therapies that will improve the efficacy of anthineoplastic drugs or decrease their intestinal toxicity.
To better understand the contribution of the microbiota in cancer, ou Biofortis Mérieux NutriSciences teams are actively contributing to research efforts through different active collaborations with preclinical and clinical groups.
I would like to thank the patients who agree to participate in these clinical studies by giving samples and filling out some tedious questionnaires.
I hope you will enjoy this new Biofortis Microbiota Newsletter dedicated to the microbiome and cancer.
Click here to request your biofortis newsletter